In recent years, in order to further accelerate the pace of development and development of the new product, the company strengthened its cooperation with internationally renowned pharmaceutical companies and research institutions. In 2012, it signed the technology authorization and cooperation agreement with Taiwan Taijing Biological Technology Co., Ltd. and Taijing Biomedical Research and Development (Beijing) Co., Ltd. and obtained the exclusive patent license of the 1.1 class innovation medicine fluorine-free quinolone "nemonoxacin" within the territory of China. Its oral ...


At present, Zhejiang Medicine Co. Ltd. is specialized in the large-scale production of fat-soluble vitamins, quasi-vitamins, quino-lone antibiotics, anti-drug-resistant antibiot- ics and other products. Its output of vitamin E is the largest domestically, and the 2nd largest globally; the output of Vancomycin hydrochloride accounts for more than 40% of the global production.

腾讯分分彩挂机思路 时时彩平台排名 双色球选6红中6全部技巧 时时彩平台一条龙 欢乐二人雀神 玩三公的技巧 微乐棋牌 金库娱乐游戏平台 pk10直播开奖赛车网站 双色球胆拖中奖计算表 时时彩大小网页计划 无错16码特围 全年 全天北京pk赛车计划 2019平特一肖免费资料 重庆时时五星彩走势图 老重时时彩走势图片